Autus Asset Management, LLC Edwards Lifesciences Corp Transaction History

Autus Asset Management, LLC

$556 Million
Q4 2022

A detailed history of Autus Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Autus Asset Management, LLC holds 63,065 shares of EW stock, worth $4.72 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

63,065

Previous 64,171 1.72%

Holding current value

$4.72 Million

Previous $5.3 Million 11.26%

% of portfolio

0.85%

Previous 1.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$68.3 - $87.44 $75,539 - $96,708	-1,106 Reduced 1.72%	63,065 $0
Q3 2022 Oct 13, 2022	SELL	$82.37 - $107.29 $10,955 - $14,269	-133 Reduced 0.21%	64,171 $5.3 Million
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $116,256 - $172,394	-1,344 Reduced 2.05%	64,304 $6.11 Million
Q1 2022 Apr 13, 2022	SELL	$101.96 - $128.34 $3.44 Million - $4.33 Million	-33,706 Reduced 33.93%	65,648 $7.73 Million
Q4 2021 Jan 14, 2022	SELL	$106.37 - $130.68 $203,698 - $250,252	-1,915 Reduced 1.89%	99,354 $12.9 Million
Q3 2021 Oct 18, 2021	SELL	$102.91 - $122.75 $272,094 - $324,551	-2,644 Reduced 2.54%	101,269 $11.5 Million
Q2 2021 Jul 16, 2021	SELL	$83.84 - $104.76 $293,188 - $366,345	-3,497 Reduced 3.26%	103,913 $10.8 Million
Q1 2021 Apr 14, 2021	BUY	$78.68 - $90.67 $577,589 - $665,608	7,341 Added 7.34%	107,410 $8.98 Million
Q4 2020 Jan 19, 2021	SELL	$71.69 - $91.23 $1 Million - $1.27 Million	-13,949 Reduced 12.23%	100,069 $9.13 Million
Q3 2020 Oct 13, 2020	SELL	$67.19 - $87.44 $31,646 - $41,184	-471 Reduced 0.41%	114,018 $9.1 Million
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $4.39 Million - $5.87 Million	76,291 Added 199.73%	114,489 $7.91 Million
Q1 2020 Apr 16, 2020	SELL	$52.41 - $81.0 $68,814 - $106,353	-1,313 Reduced 3.32%	38,198 $7.21 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $15,128 - $17,320	-211 Reduced 0.53%	39,511 $9.22 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $139,287 - $170,698	-2,263 Reduced 5.39%	39,722 $8.74 Million
Q2 2019 Jul 15, 2019	SELL	$55.74 - $64.41 $2,564 - $2,962	-46 Reduced 0.11%	41,985 $7.76 Million
Q1 2019 Apr 16, 2019	SELL	$47.89 - $64.05 $67,141 - $89,798	-1,402 Reduced 3.23%	42,031 $8.04 Million
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $34,853 - $42,761	-751 Reduced 1.7%	43,433 $6.65 Million
Q3 2018 Oct 26, 2018	SELL	$45.7 - $58.03 $42,226 - $53,619	-924 Reduced 2.05%	44,184 $7.69 Million
Q2 2018 Aug 03, 2018	SELL	$42.45 - $51.3 $50,642 - $61,200	-1,193 Reduced 2.58%	45,108 $6.57 Million
Q1 2018 Apr 24, 2018	SELL	$37.19 - $47.45 $75,718 - $96,608	-2,036 Reduced 4.21%	46,301 $6.46 Million
Q4 2017 Feb 01, 2018	SELL	$33.79 - $39.39 $14,191 - $16,543	-420 Reduced 0.86%	48,337 $5.45 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $3,919 - $4,193	108 Added 0.22%	48,757 $5.33 Million
Q2 2017 Aug 09, 2017	BUY	N/A	48,649	48,649 $5.75 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autus Asset Management, LLC with notifications on news.

Account

Autus Asset Management, LLC Edwards Lifesciences Corp Transaction History